Are Enhanced Recovery Pathways cost-effective for colorectal surgery?
Current limited evidence tends to support the cost-effectiveness of Enhanced Recovery Pathways for colorectal surgery, but well-designed trials are needed.
The quality of the current evidence is limited but tends to support the cost-effectiveness of ERP. There is need for well-designed trials to determine the cost-effectiveness of ERP from both the institutional and societal perspectives.
Lee et al. (Tue,) studied this question.